Insider Transactions in Q2 2021 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
Matthew Gall Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$130,000
$26.09 P/Share
|
|
Jun 14
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,000
-8.33%
|
$812,000
$28.82 P/Share
|
|
Jun 08
2021
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,927
-100.0%
|
$158,540
$20.0 P/Share
|
|
Jun 08
2021
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,927
+50.0%
|
$31,708
$4.23 P/Share
|
|
Jun 02
2021
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
323
-100.0%
|
$6,460
$20.0 P/Share
|
|
Jun 02
2021
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+50.0%
|
$1,292
$4.23 P/Share
|
|
Jun 01
2021
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,604
-100.0%
|
$152,080
$20.18 P/Share
|
|
Jun 01
2021
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,604
+50.0%
|
$30,416
$4.23 P/Share
|
|
May 24
2021
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,927
-100.0%
|
$166,467
$21.92 P/Share
|
|
May 24
2021
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,927
+50.0%
|
$31,708
$4.23 P/Share
|
|
May 17
2021
|
Yvonne Mc Grath Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,926
-89.67%
|
$198,150
$25.28 P/Share
|
|
May 17
2021
|
Yvonne Mc Grath Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,926
+50.0%
|
$31,704
$4.23 P/Share
|
|
Apr 09
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
119
-0.0%
|
$3,451
$29.99 P/Share
|
|
Apr 09
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
119
-0.0%
|
$3,451
$29.99 P/Share
|
|
Apr 09
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
200
-0.0%
|
$5,800
$29.99 P/Share
|
|
Apr 08
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,304
-0.26%
|
$579,120
$30.76 P/Share
|
|
Apr 08
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,304
-0.26%
|
$579,120
$30.76 P/Share
|
|
Apr 08
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,304
-0.27%
|
$969,120
$30.76 P/Share
|
|
Apr 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,670
-0.42%
|
-
|
|
Apr 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,783
-0.05%
|
$185,056
$32.92 P/Share
|
|
Apr 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,670
-0.42%
|
-
|
|
Apr 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,783
-0.05%
|
$185,056
$32.92 P/Share
|
|
Apr 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,670
-0.26%
|
-
|
|
Apr 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,678
-0.05%
|
$309,696
$32.92 P/Share
|
|
Apr 01
2021
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
421,207
+27.0%
|
$14,321,038
$34.18 P/Share
|